cellectar.comの競合サイトトップ10

precisionbiosciences.com

Precision BioSciences (“Precision BioSciences,” “us,” “we” or “our”) and our third-party providers set and use cookies and similar technologies to […]

nanobiotix.com

Discover how we leverage physics to develop scalable nanotherapeutics that can treat a range of patients.

arvinas.com

Explore career opportunities at Arvinas. Join us in advancing targeted protein degradation therapeutics.

ionetix.com

Presenter: Presenter: Dr. Richard L. Weinberg, MD, PhD. Cardiologist, Bluhm Cardiovascular Institute of Northwestern, and Assistant Professor, Feinberg School of Medicine, Northwestern University, Chicago, IL View Presentation

acimmune.com

At AC Immune, we shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science & precision medicine

mbxbio.com

Financing led by Frazier Healthcare Partners with Participation from OrbiMed and New Enterprise Associates CARMEL, Ind.- July 27, 2020 – MBX Biosciences, a drug discovery company focused in rare endocrine diseases, today announced the closing of a $34.6 million Series A financing. The financing was led by Frazier Healthcare Partners, with participation from OrbiMed, New […]

ligachembio.com

리가켐 바이오사이언스는 신약개발에 30년 이상 헌신하며 혁신적인 기술과 Open Innovation을 통해 글로벌 신약개발의 새로운 길을 개척하고 있습니다.

itftherapeutics.com

Discover the significance of DUVYZAT's FDA approval for Duchenne muscular dystrophy (DMD) patients in "A Good Day." Written by Caroline Allen, this article highlights vital information on the new treatment, its accessibility, and the resources available through ITF ARC to support patients and families navigating their treatment journey.